BOLT
BOLT
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
8
$13K
Insider Sales
3
$128K
Total Volume
$141K
16 transactions
Net Activity
$116K
Net selling
Sentiment Rating
Moderate AccumulationCEO Conviction Index
High Conviction Accumulation
Key Drivers
- •Heavy distribution: sales represent 91% of total transaction value.
- •Minor cluster buying: 2 unique insiders purchased shares.
- •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
- •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
S - Sale Insiders
$81.29M total
Quinn William P.
Pres, CEO, CFO
$65K total
Yonehiro Grant
COO
$44K total
Nemec Sarah
SVP, Finance, PAO
$32K total
Quick Actions
BOLT has an insider buy conviction of 9%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at BOLT (BOLT) engaged in a total of 16 transactions reported via SEC Form 4 filings. Among these, 8 were open-market purchases and 3 were sales. The total volume of insider trading reached $141K.
The net insider activity for BOLT shows a net selling bias of $116K. This activity represents a 9% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 13.9K shares valued at $69.31M on Dec 16, 2024.
Bolt makes inflammation play with Prana reverse merger, $120M financing
Lucid stock jumps on 25,000 robotaxi deal with Europe's Bolt
BOLT - Bolt Biotherapeutics Inc Stock Price and Quote
Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates
Bolt Biotherapeutics: BOLT Stock Price Quote & News
Shoot with confidence: Explore the best stock options for Browning X-Bolt rifles
FAQs About BOLT Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for BOLT.